DrugPatentWatch Database Preview
Details for Patent: 10,603,281
» See Plans and Pricing
Which drugs does patent 10,603,281 protect, and when does it expire?
Patent 10,603,281 protects SLYND and is included in one NDA.
This patent has forty-five patent family members in twenty-seven countries.
Summary for Patent: 10,603,281
| Title: | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| Abstract: | The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptive ("POC"), such as Drosphirenone. |
| Inventor(s): | Perrin; Philippe (Paris, FR), Velada; Jose Luis (Amersfoort, NL), Drouin; Dominique (Verrieres-le-Buisson, FR) |
| Assignee: | Laboratorios Leon Farma SA (Leon, ES) |
| Application Number: | 16/415,599 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Process; Dosage form; |
Drugs Protected by US Patent 10,603,281
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exeltis Usa Inc | SLYND | drospirenone | TABLET;ORAL | 211367-001 | May 23, 2019 | RX | Yes | Yes | Start Trial | Start Trial | PREVENTION OF PREGNANCY IN FEMALES OF REPRODUCTIVE AGE | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,603,281
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 081670 | Start Trial | |||
| Australia | 2011273605 | Start Trial | |||
| Brazil | 112012033391 | Start Trial | |||
| Brazil | 122019008317 | Start Trial | |||
| Canada | 2803721 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
